Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease

@inproceedings{Buiten2015SerumCT,
  title={Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease},
  author={Maurits S. Buiten and Mih{\'a}ly K. de Bie and Joris I. Rotmans and Friedo Wilhelm Dekker and Marjolijn van Buren and Ton J Rabelink and Christa Maria Cobbaert and Martin Jan Schalij and Arnoud van der Laarse and J Wouter Jukema and Claudio Passino},
  booktitle={PloS one},
  year={2015}
}
BACKGROUND Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients. METHODS Troponin levels… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Similar Papers

Loading similar papers…